Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $27,430 | 18 | 71.5% |
| Food and Beverage | $6,244 | 219 | 16.3% |
| Consulting Fee | $4,575 | 3 | 11.9% |
| Education | $125.72 | 3 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $13,641 | 34 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $11,225 | 20 | $0 (2020) |
| PFIZER PHARMACEUTICALS LLC | $4,575 | 11 | $0 (2020) |
| PFIZER INC. | $3,535 | 2 | $0 (2018) |
| ABBVIE INC. | $1,993 | 83 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,376 | 61 | $0 (2024) |
| Celgene Corporation | $1,200 | 2 | $0 (2024) |
| PBG PUERTO RICO LLC | $255.11 | 13 | $0 (2024) |
| CVRx, Inc. | $177.96 | 1 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $142.18 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,450 | 32 | Celgene Corporation ($600.00) |
| 2023 | $4,852 | 43 | E.R. Squibb & Sons, L.L.C. ($3,494) |
| 2022 | $10,498 | 36 | E.R. Squibb & Sons, L.L.C. ($9,922) |
| 2021 | $573.53 | 26 | AbbVie Inc. ($264.13) |
| 2020 | $2,462 | 16 | PFIZER PHARMACEUTICALS LLC ($2,100) |
| 2019 | $4,630 | 34 | PFIZER PHARMACEUTICALS LLC ($2,371) |
| 2018 | $13,496 | 39 | Merck Sharp & Dohme Corporation ($9,501) |
| 2017 | $412.85 | 17 | AbbVie, Inc. ($172.78) |
All Payment Transactions
243 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $2.50 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological), HUMIRA, RINVOQ | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.91 | General |
| Category: Neuroscience | ||||||
| 10/24/2024 | PBG PUERTO RICO LLC | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.90 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $177.96 | General |
| Category: Heart Failure and Hypertension | ||||||
| 10/03/2024 | Janssen Pharmaceuticals, Inc | STELARA (Biological) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Immunology | ||||||
| 10/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $26.00 | General |
| 09/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $31.90 | General |
| Category: IMMUNOLOGY | ||||||
| 09/10/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: VIROLOGY | ||||||
| 08/22/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.97 | General |
| Category: Neuroscience | ||||||
| 08/01/2024 | Janssen Pharmaceuticals, Inc | STELARA (Biological) | Food and Beverage | In-kind items and services | $21.40 | General |
| Category: Immunology | ||||||
| 07/30/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: VIROLOGY | ||||||
| 07/11/2024 | Janssen Pharmaceuticals, Inc | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Immunology | ||||||
| 07/09/2024 | PBG PUERTO RICO LLC | VELSIPITY (Drug) | Food and Beverage | In-kind items and services | $19.53 | General |
| Category: INFLAMMATION;PAIN | ||||||
| 06/18/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $25.00 | General |
| Category: Neuroscience | ||||||
| 05/29/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: VIROLOGY | ||||||
| 05/13/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: VIROLOGY | ||||||
| 05/09/2024 | Janssen Pharmaceuticals, Inc | STELARA (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Immunology | ||||||
| 05/08/2024 | Celgene Corporation | ZEPOSIA (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: Neuroscience | ||||||
| 05/07/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $26.25 | General |
| Category: Neuroscience | ||||||
| 04/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/18/2024 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.12 | General |
| Category: Neuroscience | ||||||
| 03/27/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 107 | 123 | $14,468 | $10,112 |
| 2022 | 5 | 123 | 165 | $16,184 | $11,197 |
| 2021 | 6 | 147 | 187 | $22,776 | $16,955 |
| 2020 | 5 | 125 | 180 | $16,511 | $12,354 |
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 46 | $4,178 | $2,887 | 69.1% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2023 | 11 | 11 | $3,798 | $2,623 | 69.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 13 | 13 | $2,259 | $1,670 | 73.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 21 | 21 | $2,370 | $1,585 | 66.9% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2023 | 29 | 32 | $1,863 | $1,348 | 72.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 64 | $5,912 | $3,910 | 66.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 19 | 19 | $3,773 | $2,703 | 71.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 24 | 24 | $2,740 | $1,750 | 63.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 29 | $2,071 | $1,562 | 75.4% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2022 | 26 | 29 | $1,688 | $1,273 | 75.4% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Office | 2021 | 13 | 13 | $5,703 | $4,491 | 78.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 47 | 63 | $5,845 | $4,145 | 70.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 18 | $3,611 | $2,728 | 75.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 32 | 32 | $3,651 | $2,465 | 67.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 13 | 31 | $2,232 | $1,785 | 80.0% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2021 | 26 | 30 | $1,734 | $1,340 | 77.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 19 | 20 | $4,122 | $3,240 | 78.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 39 | 57 | $4,355 | $2,989 | 68.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 19 | 52 | $3,829 | $2,901 | 75.8% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 24 | 24 | $2,633 | $1,977 | 75.1% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Office | 2020 | 24 | 27 | $1,571 | $1,247 | 79.4% |
About Dr. Hector Lozano, MD
Dr. Hector Lozano, MD is a Gastroenterology healthcare provider based in San Juan, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619083680.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hector Lozano, MD has received a total of $38,375 in payments from pharmaceutical and medical device companies, with $1,450 received in 2024. These payments were reported across 243 transactions from 14 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($27,430).
As a Medicare-enrolled provider, Lozano has provided services to 502 Medicare beneficiaries, totaling 655 services with total Medicare billing of $50,618. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location San Juan, PR
- Active Since 08/22/2006
- Last Updated 05/14/2012
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1619083680
Products in Payments
- ZEPOSIA (Drug) $14,241
- RENFLEXIS (Biological) $11,225
- XELJANZ (Drug) $8,206
- STELARA (Biological) $1,271
- MAVYRET (Drug) $611.79
- RINVOQ (Biological) $229.24
- SKYRIZI (Biological) $212.52
- Humira (Biological) $205.82
- Barostim Neo System (Device) $177.96
- INFLECTRA (Biological) $139.52
- Mavyret (Drug) $134.17
- CREON (Drug) $103.09
- ZYTIGA (Drug) $76.13
- Amitiza (Drug) $74.35
- HUMIRA (Biological) $68.90
- XARELTO (Drug) $51.85
- INVOKANA (Drug) $50.00
- RENFLEXIS (Drug) $42.86
- Motegrity (Drug) $38.58
- ENTYVIO (Biological) $33.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in San Juan
Dr. Henry Gonzalez-Rivera, M.d, M.D
Gastroenterology — Payments: $39,430
Dr. Rafael Rodriguez - Lopez, Md, MD
Gastroenterology — Payments: $20,525
Yahaira Moreno Denizard, M.d, M.D
Gastroenterology — Payments: $14,726
Dr. Esther Torres, M.d, M.D
Gastroenterology — Payments: $9,876
Dr. Emmanuel Reyes-Ramos, M.d, M.D
Gastroenterology — Payments: $7,845
Fernando Ramos-Mercado, Md, MD
Gastroenterology — Payments: $7,660